Posthospitalization COVID-19 cognitive deficits at 1 year are global and associated with elevated brain injury markers and gray matter volume reduction

The spectrum, pathophysiology and recovery trajectory of persistent post-COVID-19 cognitive deficits are unknown, limiting our ability to develop prevention and treatment strategies. We report the 1-year cognitive, serum biomarker and neuroimaging findings from a prospective, national study of cognition in 351 COVID-19 patients who required hospitalization, compared with 2,927 normative matched controls. Cognitive deficits were global, associated with elevated brain injury markers and reduced anterior cingulate cortex volume 1 year after COVID-19. Severity of the initial infective insult, postacute psychiatric symptoms and a history of encephalopathy were associated with the greatest deficits. There was strong concordance between subjective and objective cognitive deficits. Longitudinal follow-up in 106 patients demonstrated a trend toward recovery. Together, these findings support the hypothesis that brain injury in moderate to severe COVID-19 may be immune-mediated, and should guide the development of therapeutic strategies.

Authors

Institutions

Publication Details

Journal
Nature Medicine
Published
2024-09-23
DOI
https://doi.org/10.1038/s41591-024-03309-8
Citations
42
Primary Topic
Long-Term Effects of COVID-19
Type
article
Field-Weighted Citation Impact
15.50

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Posthospitalization COVID-19 cognitive deficits at 1 year are global and associated with elevated brain injury markers and gray matter volume reduction

Eugene Duff, Greta K. Wood, Matthew H. Hotopf, Franklyn Egbe et al.
42 citations
Nature Medicine
Long-Term Effects of COVID-19
15.50
article

Posthospitalization COVID-19 cognitive deficits at 1 year are global and associated with elevated brain injury markers and gray matter volume reduction

Eugene Duff, Greta K. Wood, Matthew H. Hotopf, Franklyn Egbe, Timothy R. Nicholson, Gerome D. Breen, Tom Solomon, Anthony S. David, Patrick Francis Chinnery, Richard A. I. Bethlehem, Kukatharmini Tharmaratnam, Thomas Jackson, William R. Trender, Sarah Pett, Colm Cunningham, E. Charles Leek, Nathalie Kingston, Fernando Zelaya, Matthew R. Broome, Guy Williams, Masud Husain, Adam Hampshire, Brendan Sargent, Thomas Pollak, Edward Needham, Edward Thomas Bullmore, Valentina Giunchiglia, Steven Williams, Daniel J. van Wamelen, Neil Andrew Harrison, Ava Easton, Alan Carson, Gursharan Kalsi, Rachel Upthegrove, David Krishna Menon, Cordelia Dunai, Angela Vincent, John P. Aggleton, Nicholas William Wood, Stephen M. Smith, Simon S. Keller, Henry C. Rogers, Naomi Martin, John R. Bradley, Karla L. Miller, Peter John Hellyer, Peter Jezzard, Christopher Hübel, Zain Ahmad, Bethany Facer, Pamela J. Shaw, John‐Paul Taylor, Sophie Pendered
article en
42 citations

Abstract

The spectrum, pathophysiology and recovery trajectory of persistent post-COVID-19 cognitive deficits are unknown, limiting our ability to develop prevention and treatment strategies. We report the 1-year cognitive, serum biomarker and neuroimaging findings from a prospective, national study of cognition in 351 COVID-19 patients who required hospitalization, compared with 2,927 normative matched controls. Cognitive deficits were global, associated with elevated brain injury markers and reduced anterior cingulate cortex volume 1 year after COVID-19. Severity of the initial infective insult, postacute psychiatric symptoms and a history of encephalopathy were associated with the greatest deficits. There was strong concordance between subjective and objective cognitive deficits. Longitudinal follow-up in 106 patients demonstrated a trend toward recovery. Together, these findings support the hypothesis that brain injury in moderate to severe COVID-19 may be immune-mediated, and should guide the development of therapeutic strategies.

Nature MedicineVol. 31(1)
Queen's University Belfast (GB), Belfast Health and Social Care Trust (GB), NHS Lothian (GB), University of Nottingham (GB), Radboud University Nijmegen (NL), University of Liverpool (GB), Queen Mary University of London (GB), University of Dundee (GB), King's College London (GB), Liverpool School of Tropical Medicine (GB), South London and Maudsley NHS Foundation Trust (GB), Aarhus University (DK), Trinity College Dublin (IE), Cumbria Northumberland Tyne and Wear NHS Foundation Trust (GB), University of Cambridge (GB), Aintree University Hospitals NHS Foundation Trust (GB), Royal Stoke University Hospital (GB), Mental Health Research UK (GB), Cambridge University Hospitals NHS Foundation Trust (GB), Millennium Science Initiative (CL), John Radcliffe Hospital (GB), Edinburgh Royal Infirmary (GB), Walton Centre (GB), Stroke Association (GB), Radboud University Medical Center (NL), Warneford Hospital (GB), University of Manchester (GB), Northern Health and Social Care Trust (GB), National Institute for Health and Care Research (GB), University of Oxford (GB), Cambridge School (PT), MRC Clinical Trials Unit at UCL (GB), Institute of Mental Health (GB), Wellcome Centre for Integrative Neuroimaging (GB), Sheffield Teaching Hospitals NHS Foundation Trust (GB), Gateshead Health NHS Foundation Trust (GB), Salford Royal Hospital (GB), UK Dementia Research Institute (GB), Encephalitis Society (GB), King's College Hospital (GB), Birmingham Women’s and Children’s NHS Foundation Trust (GB), Institute of Genetics (HU), Health Protection Research Unit in Emerging and Zoonotic Infections at University of Liverpool (GB), University of Southampton (GB), University College London (GB), Imperial College London (GB), Charité - Universitätsmedizin Berlin (DE), University of Glasgow (GB), MRC Mitochondrial Biology Unit (GB), Cardiff University (GB), University of Birmingham (GB), Newcastle University (GB), University of Sheffield (GB), University of Edinburgh (GB)
Wellcome, Wellcome Trust, UK Research and Innovation, National Institute for Health Research Health Protection Research Unit, International Seafood Sustainability Foundation, National Institute for Health and Care Research, King's College London, NIHR BioResource, NIHR Maudsley Biomedical Research Centre, Medical Research Council, NIHR Newcastle Biomedical Research Centre
Openalex Percentile: Top 1%
Long-Term Effects of COVID-19
15.50
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.